<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mesenchymal stem cells (MSCs) have emerged as excellent candidates for clinical application because of their capabilities of immunomodulatory and supporting hematopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless, it is unclear whether the characteristics of MSCs are altered in diseased states </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we obtained and expanded MSCs from bone marrow of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Our results showed that MSCs derived from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs) were similar to <z:mpath ids='MPATH_458'>normal</z:mpath> adult bone marrow derived MSCs in <z:mp ids='MP_0000002'>morphology</z:mp>, growth property, surface <z:chebi fb="0" ids="53000">epitopes</z:chebi>, and differentiation ability in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs had <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype and ultrastructure </plain></SENT>
<SENT sid="5" pm="."><plain>However, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs appeared to be impaired in immunomodulatory and supporting hematopoiesis function </plain></SENT>
<SENT sid="6" pm="."><plain>Although, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs could express hematopoietic cytokines and support hematopoiesis in long term culture, Real time quantitative polymerase chain reaction showed that the expression of hematopoietic cytokines in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs was much lower than that of <z:mpath ids='MPATH_458'>normal</z:mpath> adult derived MSCs </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs showed <z:mp ids='MP_0001606'>reduced hematopoiesis</z:mp> support function, as compared to their <z:mpath ids='MPATH_458'>normal</z:mpath> counterparts </plain></SENT>
<SENT sid="8" pm="."><plain>Lastly, the capacity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs to inhibit T lymphocyte activation and proliferation was impaired in vitro </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MSCs have impaired immunomodulatory and hematopoiesis support functions, suggesting their critical role in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>